scispace - formally typeset
V

Verena S. Hoffmann

Researcher at Ludwig Maximilian University of Munich

Publications -  63
Citations -  2748

Verena S. Hoffmann is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Population & Placebo. The author has an hindex of 20, co-authored 57 publications receiving 2258 citations.

Papers
More filters
Journal ArticleDOI

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

TL;DR: A new prognostic score that is superior to the Sokal and Euro scores both in its prognostic ability and in its simplicity is described, which can be used to identify CML patients with significantly lower probabilities of responding to therapy and survival, thus alerting physicians to those patients who require closer observation and early intervention.
Journal ArticleDOI

Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-analysis

TL;DR: In this article, the authors summarize available evidence on the predictive value of CT severity parameters for short-term clinical outcome in pulmonary embolism and find that an abnormally increased RV/left ventricular diameter ratio measured on transverse sections was associated with an approximately 2.5-fold risk for all-cause mortality (pooled odds ratio [OR],2.5; 95% confidence interval [CI], 1.8-3.5) and adverse outcome (OR, 2.6-3).
Journal ArticleDOI

Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia

TL;DR: This work tackled the reassessment of prognosis under particular consideration of the probabilities of dying of CML and determined a new long-term survival score with three prognostic groups, which supports the prospective assessment of long- term antileukemic efficacy and risk-adapted treatment.